Wound Care Biologics Market by Region - Global Industry Insights, and Forecast to 2025

 

Wound Care Biologics Market

Bioengineered products called wound care biologics are used to treat non-healing lower extremity wounds. As early intervention of diabetic ulcers can prevent serious complications like infection, hospitalisation, and amputation, demand for wound care biologic products is anticipated to rise significantly. Since the commercially available skin substitutes have clinical and experimental evidence of efficacy in wound healing, the market for wound care biologics is anticipated to grow significantly.

Given that diabetic patients are more likely to develop diabetic ulcers, the market for wound care biologics is anticipated to grow significantly with the rise in the prevalence of diabetes worldwide. According to the Global Diabetes Community, 642 million adults will have diabetes worldwide by 2040, up from an estimated 422 million in 2017. Peripheral neuropathy, foot ulceration, and peripheral arterial disease (PAD) are twice as common in diabetic patients as they are in non-diabetics, affecting 30% of diabetics aged 40 and older, according to the Journal of Foot and Ankle Surgery, 2016. This has led to an increase in the burden of diabetic complications.

The Global Wound Care Biologics Market Was Valued At US$ 1.2 Billion In 2016 And Is Expected To Exhibit A Robust CAGR Of 6.9% Over The Forecast Period (2017–2025).

Additionally, according to the Advances in Wound Care Journal from 2015, 15% to 20% of people with diabetes are likely to experience chronic, non-healing foot wounds. In order to manage chronic wounds affordably and lessen the financial burden of the patients, wound care biologic products are offered to them. The high cost of skin substitutes and associated biologics, however, is a significant barrier to the market's expansion. For instance, the Advances in Skin Substitutes Journal (2014) estimates that the cost of using Epicel to cover 1% of a body's surface area will be more than $13,000. As a result, alternative and less expensive wound care products are adopted more frequently, which is expected to have a negative impact on market growth.

Over the course of the forecast, Asia Pacific is anticipated to experience significant growth in the global market for wound care biologics. The high prevalence of diabetic patients in Asian nations is to blame for this. In 2016, the Indian Diabetes Research Foundation estimates that 60% of people with diabetes live in Asia, with China and India accounting for the majority of those cases. The Foundation also notes that Western Pacific reported having more than 138.2 million diabetics, with a projected increase to 201.8 million by 2035.

Moreover, a significant factor in the market's growth is the expansion of medical tourism in Asia and the Pacific. The number of foreign patients is rising as a result of hospitals offering more affordable treatment options for managing wounds. In 2017, approximately 4 million medical tourists travelled to India for medical treatment, 3.5 million foreign patients travelled to Thailand for medical treatment, and 900,000 patients travelled to Singapore for medical treatment. This number is predicted to increase by 10% to 14% by 2020, according to a survey by the Brink Global Risk Center.

Because chronic non-healing wounds are becoming more common and cost the healthcare system money, North America is predicted to dominate the wound care biologics market. The average cost of treating a single foot ulcer in 2016 was $8,000, and the average cost of a major amputation was $45,000, according to the American Diabetes Association. Additionally, with nearly 2 million cases, venous leg ulcers are the most prevalent type of wound in the United States.

Major Companies involved are- Smith & Nephew Plc., Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amino Technology LLC, and Osiris Therapeutics, Inc.

Press Release for Wound Care Biologics Market

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more